Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

KEYNOTE 10: Pembrolizumab vs docetaxel for NSCLC

Dr Roy S. Herbst - Yale Cancer Centre, New Haven, USA
KEYNOTE 10: Pembrolizumab vs docetaxel for NSCLC ( Dr Roy S. Herbst - Yale Cancer Centre, New Haven, USA )
21 Oct 2018

Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic urothelial carcinoma

Dr Jonathan E. Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, USA
Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic urothelial carcinoma ( Dr Jonathan E. Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, USA )
21 Oct 2018

The past, present and future of treating ovarian cancer

Dr Susana Banerjee - The Institute of Cancer Research, London, UK
The past, present and future of treating ovarian cancer ( Dr Susana Banerjee - The Institute of Cancer Research, London, UK )
21 Oct 2018

Comment on SOLO-1 for advanced ovarian cancer

Dr Jonathan Ledermann - University College London, London, UK
Comment on SOLO-1 for advanced ovarian cancer ( Dr Jonathan Ledermann - University College London, London, UK )
21 Oct 2018

Olaparib improves progression free survival up front in ovarian cancer

Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA
Olaparib improves progression free survival up front in ovarian cancer ( Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA )
21 Oct 2018

A novel bifunctional fusion protein for combatting lung cancer

Dr Luis Paz-Ares - Hospital Universitario, Madrid, Spain
A novel bifunctional fusion protein for combatting lung cancer ( Dr Luis Paz-Ares - Hospital Universitario, Madrid, Spain )
21 Oct 2018

Comment on new treatment options for breast cancer

Prof Nadia Harbeck - Klinikum der Universität München, Munich, Germany
Comment on new treatment options for breast cancer ( Prof Nadia Harbeck - Klinikum der Universität München, Munich, Germany )
20 Oct 2018

Early stage trials in immunotherapy and brain screening

Dr Elena Garralda - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Early stage trials in immunotherapy and brain screening ( Dr Elena Garralda - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
20 Oct 2018

Alpelisib and fulvestrant for advanced breast cancer: SOLAR-1

Prof Fabrice André - Institut Gustave Roussy, Paris, France
Alpelisib and fulvestrant for advanced breast cancer: SOLAR-1 ( Prof Fabrice André - Institut Gustave Roussy, Paris, France )
20 Oct 2018

Results from the IMpassion130 trial for triple-negative breast cancer

Prof Peter Schmid - St Bartholomew Hospital London, UK
Results from the IMpassion130 trial for triple-negative breast cancer ( Prof Peter Schmid - St Bartholomew Hospital London, UK )
20 Oct 2018

Economics and education around biosimilars

Prof Arnold G. Vulto - Erasmus MC, Rotterdam, Netherlands
Economics and education around biosimilars ( Prof Arnold G. Vulto - Erasmus MC, Rotterdam, Netherlands )
20 Oct 2018

Results from the SOLAR-1 trial for advanced breast cancer

Prof Fabrice André - Institut Gustave Roussy, Paris, France
Results from the SOLAR-1 trial for advanced breast cancer ( Prof Fabrice André - Institut Gustave Roussy, Paris, France )
20 Oct 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation